Elevance Health Inc (ELV) Financials

$419.75

$-4.49 (-1.06%)

As on 15-Sep-2026 13:44EDT

Market cap

$90,335 Mln

Revenue (TTM)

$201,113 Mln

P/E Ratio

17.5

P/B Ratio

1.9

Div. Yield

1.7 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	201,113.00	199,125.00	176,810.00	171,340.00	156,595.00	138,639.00
Cost of Revenue	122,775.00	148,223.00	127,567.00	124,330.00	116,642.00	102,645.00
Gross Profit	78,338.00	50,902.00	49,243.00	47,010.00	39,953.00	35,994.00
Operating Expenses	71,276.00	42,790.00	40,355.00	38,265.00	31,502.00	27,048.00
Operating Profit (EBIT)	7,062.00	8,112.00	8,888.00	8,745.00	8,451.00	8,946.00
Other Income	--	--	--	--	--	--
Profit before Tax	5,862.00	6,710.00	7,904.00	7,715.00	7,600.00	7,925.00
Provision for Tax	915.00	1,049.00	1,933.00	1,724.00	1,712.00	1,830.00
Profit after Tax (Net Income)	4,963.00	5,662.00	5,980.00	5,987.00	5,894.00	6,104.00
Minority Interest	16.00	1.00	9.00	-41.00	6.00	9.00
Consolidated Profit	1,736.00	5,662.00	5,980.00	5,987.00	6,025.00	6,104.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	44,883.00	43,882.00	41,315.00	39,306.00	36,243.00	36,060.00
Minority Interest	16.00	--	--	--	87.00	68.00
Non-Current Liabilities	48,637.00	57,511.00	56,042.00	49,972.00	47,771.00	45,807.00
Current Liabilities	32,779.00	19,957.00	19,421.00	19,551.00	18,654.00	15,525.00
Total Liabilities	159,217.00	121,494.00	116,889.00	108,928.00	102,755.00	97,460.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	59,254.00	96,768.00	95,546.00	89,942.00	83,622.00	82,889.00
Current Assets	67,184.00	24,726.00	21,343.00	18,986.00	19,133.00	14,571.00
Total Assets	193,622.00	121,494.00	116,889.00	108,928.00	102,755.00	97,460.00
Total Debt*	31,044.00	33,235.00	32,701.00	26,654.00	25,797.00	24,892.00
Net Current Assets	--	--	--	--	--	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	4,290.00	5,808.00	8,061.00	8,399.00	8,364.00
Cash Flow from Investing Activities	--	-1,344.00	-5,167.00	-5,572.00	-4,560.00	-9,638.00
Cash from Financing Activities	--	-1,738.00	1,193.00	-3,349.00	-1,318.00	423.00
Net Cash Inflow / Outflow	--	--	--	--	2,521.00	-861.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	22.45	25.53	25.88	25.39	24.44	24.86
Cash EPS ($)	--	32.50	31.90	33.00	31.38	30.17
Adjusted Book Value ($)	--	197.84	178.78	166.69	150.26	146.88
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	19.34	25.13	34.19	34.82	34.07
Free Cash Flow per Share ($)	--	14.31	19.70	28.69	30.05	29.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	7.49	8.54	9.35	9.58	10.53
ROE (%)	11.22	13.29	14.83	15.85	16.30	17.63
ROA (%)	2.92	4.75	5.30	5.66	5.89	6.57
EBIT Margin (%)	3.48	4.07	5.14	5.10	5.40	6.29
Net Margin (%)	2.47	2.84	3.38	3.49	3.76	4.40
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	6.27	0.13	0.03	0.09	0.13	0.14
EBIT Growth (%)	-16.69	-10.75	3.93	3.48	-3.12	24.22
Net Profit Growth (%)	-7.30	-5.32	-0.12	1.58	-3.44	33.51
EPS Growth (%)	-4.45	-0.01	0.02	0.04	-0.02	0.37
Book Value Growth (%)	6.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	17.55	13.73	14.26	18.57	20.99	18.64
Price / Book Value	1.92	1.77	2.06	2.83	3.41	3.16
Dividend Yield (%)	1.74	--	--	--	--	--
EV/EBITDA	--	7.83	8.06	9.70	11.47	10.73
Close Price ($)	386.73	350.55	368.90	471.56	512.97	463.54
High Price ($)	426.98	458.75	567.26	514.06	549.52	470.02
Low Price ($)	273.71	273.71	362.21	412.00	420.73	286.04
Market Cap ($ Cr)	90,334.74	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.68	0.76	0.79	0.68	0.71	0.69
Short term debt to equity ratio	0.01	0.03	0.05	0.05	0.05	0.06
Current Ratio	2.05	1.24	1.10	0.97	1.03	0.94
Quick Ratio	2.05	--	--	3.34	1.64	3.42
Interest Coverage	6.19	5.79	7.67	8.49	9.93	10.93

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	11.63	7.65	7.38	7.27	7.50	6.99
Asset Turnover	1.18	1.67	1.57	1.62	1.56	1.49
Receivable days	--	25.95	26.35	25.80	25.00	23.47
Inventory Days	--	--	-132.66	-84.77	-78.07	-129.55
Payable days	--	40.45	45.61	46.57	45.58	44.26
Cash Conversion Cycle	--	--	-151.91	-105.55	-98.65	-150.34

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)